MIRM
Mirum Pharmaceuticals Inc
79.30$
-2.7%
vs. previous close
Closing price · As of: Oct 6, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -38.2% | -23.9% | 22.0% | -4.9% | 4.4% | -5.1% | -1.8% | 9.4% | 29.8% | 4.1% | -143.1% | -154.9% | -73.8% | |
| 5.6% | 7.9% | 8.2% | 7.5% | 6.7% | 6.1% | 5.4% | 4.7% | 4.6% | 4.1% | 4.3% | 7.8% | 5.3% | |
| 17.6% | 14.0% | 16.5% | 15.2% | 13.2% | 13.3% | 14.2% | 14.5% | 13.6% | 12.8% | 22.6% | 37.9% | 22.7% | |
| 16.2% | – | – | – | – | – | – | – | – | – | – | – | – | |
| -11.8% | -15.6% | 34.6% | 2.0% | -1.4% | -1.7% | -10.1% | -5.1% | 9.1% | -9.4% | 63.9% | 35.2% | 26.3% | |
| 0.0% | 7.2% | 0.0% | 13.8% | 11.3% | 0.0% | 0.0% | 0.1% | 0.1% | 0.4% | 0.4% | 0.4% | 0.3% | |
| -382.9% | -2.9% | 0.0% | -93.4% | -20.0% | 0.6% | -14.5% | -5.2% | -1.7% | 0.7% | -7.2% | -97.3% | -29.8% | |
| – | – | 0.0% | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | 0.0% | 0.0% | – | – | – | – | – | – | – | |
| 434.0% | 2.6% | 1.7% | 9.4% | 4.3% | 5.4% | 5.7% | 6.8% | 12.1% | 6.0% | 168.9% | 273.2% | 125.7% | |
| 12.2% | -24.1% | 23.9% | -89.1% | -11.2% | -0.5% | -9.6% | 12.8% | 40.5% | 10.5% | 17.7% | 19.5% | 21.4% | |
| -38.2% | -31.1% | 22.0% | -18.7% | -6.9% | -5.1% | -1.8% | 9.3% | 29.7% | 3.7% | -143.5% | -155.3% | -74.1% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 6, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.